FIELD: medicine; pharmaceuticals.
SUBSTANCE: present invention relates to a compound with structural formula (I) or its pharmaceutically acceptable salt or enantiomer; where R1 is hydrogen or RlaC(O)-; R2 is hydrogen or a R2aC(O)-; R3 is hydrogen or a R3aC(O)-; Rla, R2a and R3a independently are unsubstituted with C1-C10 alkyl; and R4 and R5 independently represent hydrogen or unsubstituted with C1-C10 alkyl; however provided that at least one of R1, R2 and R3 is not hydrogen.
EFFECT: bimatoprost derivatives are effective for treatment of such diseases or disorders, as high intraocular pressure, hair loss, inflammatory diseases and disorders of skin.
10 cl, 6 tbl, 16 dwg, 18 ex
Title | Year | Author | Number |
---|---|---|---|
VEGF NEUTRALISING PRODRUGS FOR THE TREATMENT OF OCULAR CONDITIONS | 2013 |
|
RU2673881C2 |
5,5-CONDENSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITORS | 2010 |
|
RU2554087C2 |
DIAGNOSIS, PREVENTION AND TREATMENT OF JOINT DISEASES | 2013 |
|
RU2682676C2 |
PURINE DERIVATIVES FOR APPLICATION AS AGONISTS OF ADENOSINE RECEPTOR A-2A | 2005 |
|
RU2403253C2 |
CHEMOKINE RECEPTOR MODULATORS AND USE THEREOF | 2017 |
|
RU2768827C2 |
3-PHENYL-BENZOFURAN-2-ONIC DERIVATIVES CONTAINING PHOSPHORUS, AS STABILIZERS | 2016 |
|
RU2722188C2 |
CONDENSED HETEROCYCLIC COMPOUND | 2009 |
|
RU2480473C2 |
ORGANIC COMPOUNDS | 2003 |
|
RU2478378C2 |
USING SIP RECEPTOR MODULATOR | 2008 |
|
RU2498796C2 |
3-PHENYL-BENZOFURAN-2-ONE DERIVATIVES CONTAINING PHOSPHORUS AS STABILISERS | 2015 |
|
RU2678660C2 |
Authors
Dates
2016-10-10—Published
2012-02-13—Filed